Trump Unveils Up to 100% Tariffs on Imported Medicines With Key Exemptions [Yahoo! Finance]
Merck & Company, Inc. (new) (MRK)
Last merck & company, inc. (new) earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.merck.com/home/default.aspx
Company Research
Source: Yahoo! Finance
pharmaceutical trade, imposing duties of up to 100% on certain imported patented medicines while embedding a range of carve-outs that may soften the immediate impact. The policy targets drugs produced in countries without trade agreements and companies that have not accepted most-favored-nation pricing terms, with implementation staggered120 days for larger manufacturers and 180 days for smaller ones. At the same time, imports from jurisdictions that reached agreements with Washington, including the European Union, Japan, South Korea, Switzerland, and Liechtenstein, will face capped tariffs of 15%, while the United Kingdom's rate sits at 10% with the potential to fall to zero if domestic manufacturing commitments are finalized, highlighting a structure designed to incentivize production shifts rather than impose uniform penalties. Warning! GuruFocus has detected 1 Warning Sign with MSFT. Is MRK fairly valued? Test your thesis with our free DCF calculator. Underneath that headlin
Show less
Read more
Impact Snapshot
Event Time:
MRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRK alerts
High impacting Merck & Company, Inc. (new) news events
Weekly update
A roundup of the hottest topics
MRK
News
- Merck & Co., Inc. (MRK) had its price target raised by JPMorgan Chase & Co. from $125.00 to $135.00. They now have an "overweight" rating on the stock.MarketBeat
- Trump's 100% tariffs on drugs could cost you more at the pharmacy [Los Angeles Times (CA)]Los Angeles Times
- Want to work for one of America's best companies? These 3 N.J. employers made the cut. [Yahoo! Finance]Yahoo! Finance
- Merck & Co. (MRK) Announces Detailed Results From the Phase 2 CADENCE Study [Yahoo! Finance]Yahoo! Finance
- Merck Announces Initiation of Pivotal Phase 2b/3 Trial Evaluating MK-8748 (Tiespectus), an Investigational Bispecific Tie2 Agonist/VEGF Inhibitor, for the Treatment of Neovascular Age-Related Macular Degeneration [Yahoo! Finance]Yahoo! Finance
MRK
Earnings
- 2/3/26 - Beat
MRK
Sec Filings
- 4/1/26 - Form 4
- 4/1/26 - Form 4
- 4/1/26 - Form 4
- MRK's page on the SEC website